Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15740935rdf:typepubmed:Citationlld:pubmed
pubmed-article:15740935lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:15740935lifeskim:mentionsumls-concept:C0012133lld:lifeskim
pubmed-article:15740935lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15740935lifeskim:mentionsumls-concept:C0069733lld:lifeskim
pubmed-article:15740935pubmed:issue1-2lld:pubmed
pubmed-article:15740935pubmed:dateCreated2005-3-2lld:pubmed
pubmed-article:15740935pubmed:abstractTextThe combined effect against human immunodeficiency virus (HIV) of oxanosine and 2'3'-dideoxyinosine (ddI) has been evaluated by the production of viral particles, the expression of viral antigens on cell surfaces, and the amount of viral genome integrated in the host cells. Oxanosine alone has no effect on HIV replication up to 100 microg/ml, however, in the presence of ddI, oxanosine revealed concentration dependent inhibition against HIV without cytotoxicity.lld:pubmed
pubmed-article:15740935pubmed:languageenglld:pubmed
pubmed-article:15740935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15740935pubmed:citationSubsetIMlld:pubmed
pubmed-article:15740935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15740935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15740935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15740935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15740935pubmed:statusMEDLINElld:pubmed
pubmed-article:15740935pubmed:issn0753-3322lld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:UmezawaKazuoKlld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:OhnoTsuneyaTlld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:NakamuraMarik...lld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:YokonoAkiraAlld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:NakamoriShogo...lld:pubmed
pubmed-article:15740935pubmed:authorpubmed-author:OgawaTomooTlld:pubmed
pubmed-article:15740935pubmed:issnTypePrintlld:pubmed
pubmed-article:15740935pubmed:volume59lld:pubmed
pubmed-article:15740935pubmed:ownerNLMlld:pubmed
pubmed-article:15740935pubmed:authorsCompleteYlld:pubmed
pubmed-article:15740935pubmed:pagination47-50lld:pubmed
pubmed-article:15740935pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:meshHeadingpubmed-meshheading:15740935...lld:pubmed
pubmed-article:15740935pubmed:articleTitleSynergistic anti-viral effect of oxanosine and ddI against human immunodeficiency virus.lld:pubmed
pubmed-article:15740935pubmed:affiliationDepartment of Microbiology, The Jikei University School of Medicine 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461 Japan. nakamura@jikei.ac.jplld:pubmed
pubmed-article:15740935pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15740935pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15740935pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed